Awards & Other Accomplishments Archives | Page 7 of 37 | Be Korea-savvy

Archive by category Awards & Other Accomplishments

Nasdaq Rises to 5th in RiskTech100 Global Ranking Following Launch of Financial Technology Division

Nasdaq Rises to 5th in RiskTech100 Global Ranking Following Launch of Financial Technology Division

Announcement comes ahead of the first anniversary of Nasdaq’s acquisition of Adenza Nasdaq also wins two awards for its financial crime management and regulatory reporting technology NEW YORK, Oct. 10, 2024 (Korea Bizwire) – Nasdaq (Nasdaq: NDAQ) today announced it has jumped to 5th place in Chartis’ annual RiskTech100® global ranking and has won two awards for [...]

Ascom has been awarded a major contract by the Canton of Zurich to install Ascom’s new Security Support System in nine penal institutions

Ascom has been awarded a major contract by the Canton of Zurich to install Ascom’s new Security Support System in nine penal institutions

Baar, Switzerland, 10 October 2024 Ascom is pleased to announce the expansion of its innovative App “Security Support System”, to nine penal institutions in Canton Zurich. The rollout of the first installation in Winterthur’s prison is scheduled for late 2024 and will continue through 2026 to eight additional correctional facilities in Canton Zurich. The entire project [...]

Bitget Integrates GMCI Indices Enabling Curated-Secured Trading

Bitget Integrates GMCI Indices Enabling Curated-Secured Trading

VICTORIA, Seychelles, Oct. 09, 2024 (Korea Bizwire) – Bitget, the world’s leading cryptocurrency exchange and Web3 company, has announced the addition of the GMCI indices to its futures market, enabling traders to access a diversified range of assets securely. The GMCI indices are curated based on strict criteria to ensure a verified overview of the market. For any coin [...]

Australia’s TPG Telecom Taps Mavenir to Boost Voice Security For Mobile Users and Block AI-Driven Scam Calls

Australia’s TPG Telecom Taps Mavenir to Boost Voice Security For Mobile Users and Block AI-Driven Scam Calls

RICHARDSON, Texas, Oct. 09, 2024 (Korea Bizwire) – Mavenir, the Network Software Provider building the future of networks with cloud-native solutions that run on any cloud, today announces that its advanced machine learning (ML) technology is being used by TPG Telecom to protect mobile users from the increasing scourge of AI-driven scam and spam voice [...]

World Economic Forum recognizes Schneider Electric Shanghai, China and Monterrey, Mexico factories as new Lighthouses

World Economic Forum recognizes Schneider Electric Shanghai, China and Monterrey, Mexico factories as new Lighthouses

Monterrey 1 new Advanced Lighthouse and Shanghai new End-to-End Value Chain Lighthouse, the company now has seven factories that have achieved Lighthouse statusThese are leading examples of how Fourth Industrial Revolution technologies can be leveraged for better sustainability and operational results Rueil-Malmaison, France, Oct. 08, 2024 (Korea Bizwire) – Schneider Electric, the leader in the digital [...]

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal women TVB-009P, Teva’s proposed biosimilar to Prolia, showed Phase 3 clinical results in osteoporosis and is part of Teva’s robust biosimilar portfolio – 7 approved biosimilars and 16 in the pipeline – across critical therapeutic areas such [...]

Mavenir 5G Core Powers ice Norway Network Slicing for Norwegian Armed Forces

Mavenir 5G Core Powers ice Norway Network Slicing for Norwegian Armed Forces

Commercial 5G Standalone Enabling secure tailored end-to-end communications Dedicated slices to meet specific needs of the Armed Forces Extending strategic partnership with key customer OSLO, Norway, Oct. 08, 2024 (Korea Bizwire) – Mavenir, the cloud-native network infrastructure provider building the future of networks, is delivering the full 5G core network for ice, Norway’s third largest mobile [...]

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on survodutide’s groundbreaking results from Phase II  study1 Boehringer launches two Phase III studies of survodutide, LIVERAGE in adults with MASH and moderate or advanced fibrosis, and LIVERAGE-Cirrhosis in those with [...]

20 Years Strong: RIB CostX Marks Two Decades of Revolutionizing the Construction Industry

20 Years Strong: RIB CostX Marks Two Decades of Revolutionizing the Construction Industry

RIB Software, a global leader in construction software solutions, this year celebrates 20 years of its award-winning all-in-one takeoff, estimating, and reporting software, RIB CostX. BRISBANE, Oct. 2 (Korea Bizwire) – RIB Software, a global leader in construction software solutions, this year celebrates 20 years of its award-winning all-in-one takeoff, estimating, and reporting software, RIB CostX.  [...]

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan to initiate dosing of Phase 1/2 in Q4 2024 to evaluate REC-1245 in a biomarker enriched patient population, including patients with solid tumors and lymphoma SALT LAKE CITY, Oct. 02, [...]